Suppr超能文献

全州范围的处方药物监测计划对阿片类药物处方模式的影响。

The effect of a statewide prescription drug monitoring program on opioid prescribing patterns.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Boston Medical Center, 800 Harrison Ave BCD 5th floor, Boston, MA 02118, United States of America; Boston University School of Medicine, 72 East Concord St, Boston, MA 02118, United States of America.

Department of Otolaryngology-Head and Neck Surgery, Boston Medical Center, 800 Harrison Ave BCD 5th floor, Boston, MA 02118, United States of America; Boston University School of Medicine, 72 East Concord St, Boston, MA 02118, United States of America.

出版信息

Am J Otolaryngol. 2022 Jan-Feb;43(1):103262. doi: 10.1016/j.amjoto.2021.103262. Epub 2021 Oct 1.

Abstract

PURPOSE

Determine whether opioid prescribing patterns have changed as a result of implementation of a prescription drug monitoring program (PDMP) in the state of Massachusetts.

MATERIALS AND METHODS

A multicentered retrospective study was performed including patients who received tonsillectomy, parotidectomy, thyroidectomy or direct laryngoscopy and biopsy with or without rigid esophagoscopy and/or rigid bronchoscopy at Lahey Hospital and Medical Center (Burlington, MA) or Boston Medical Center (Boston, MA). Opioid prescribing patterns were compared for the 12 months prior to implementation of the Massachusetts Prescription Awareness Tool (MassPAT) to 36 months of prescribing patterns post implementation. Quantity of opioids prescribed was based on morphine milligram equivalents (MME). Continuous variables were compared using analysis of variance (ANOVA) while categorical variables were compared using chi-squared test or Fisher's exact test. Multivariate analysis was performed using linear regression.

RESULTS

A total of 2281 patients were included in the study. There was a significant association in mean overall MME prescribed comparing pre-MassPAT and post-MassPAT data [tonsillectomy: 635.9 ± 175.6 vs 463.3 ± 177.7 (p < 0.0001), parotidectomy: 250.4 ± 71.33 vs 169.8 ± 79.26 (p < 0.0001), thyroidectomy: 186.2 ± 81.14 vs 118.3 ± 88.79 (p < 0.0001), direct laryngoscopy with biopsy: 308.3 ± 246.9 vs 308.3 ± 246.9 (p = 0.0201)]. There was also a significant association between length of opioid prescription (days) and implementation of MassPAT, but there was no significant difference in the percent of patients requiring refills pre- MassPAT and post-MassPAT.

CONCLUSION

This study demonstrates that prescribers have been able to significantly decrease the amount of opioids prescribed for tonsillectomy, parotidectomy, thyroidectomy, and direct laryngoscopy and biopsy and patients have not required additional opioid refills.

摘要

目的

确定马萨诸塞州实施处方药物监测计划(PDMP)后,阿片类药物的开具模式是否发生了变化。

材料和方法

本研究为多中心回顾性研究,包括在莱希医院和医疗中心(马萨诸塞州伯灵顿)或波士顿医疗中心(马萨诸塞州波士顿)接受扁桃体切除术、腮腺切除术、甲状腺切除术或直接喉镜检查和/或硬性食管镜检查和/或硬性支气管镜检查的患者。在实施马萨诸塞州处方意识工具(MassPAT)之前的 12 个月和实施后的 36 个月内,比较阿片类药物的开具模式。开具的阿片类药物数量基于吗啡毫克当量(MME)。连续变量采用方差分析(ANOVA)进行比较,分类变量采用卡方检验或 Fisher 精确检验进行比较。采用线性回归进行多变量分析。

结果

本研究共纳入 2281 例患者。与 MassPAT 前和 MassPAT 后数据相比,总体 MME 平均处方量存在显著相关性[扁桃体切除术:635.9±175.6 与 463.3±177.7(p<0.0001),腮腺切除术:250.4±71.33 与 169.8±79.26(p<0.0001),甲状腺切除术:186.2±81.14 与 118.3±88.79(p<0.0001),直接喉镜检查伴活检:308.3±246.9 与 308.3±246.9(p=0.0201)]。在处方天数与 MassPAT 实施之间也存在显著相关性,但在 MassPAT 前和 MassPAT 后需要药物补充的患者比例上没有显著差异。

结论

本研究表明,医生已显著减少了扁桃体切除术、腮腺切除术、甲状腺切除术和直接喉镜检查伴活检的阿片类药物开具量,且患者无需额外开具阿片类药物补充。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验